心肺运动试验标准用于当代动态心衰患者心脏移植转诊的评估
该研究回顾性分析8060例动态心衰患者,聚焦1218例左室射血分数<40%且峰值耗氧量<12 mL/kg/min者,比较其生存结局与国际心肺移植注册中心移植受者。发现峰值耗氧量<12 mL/kg/min者生存优于移植受者,约2.7年曲线交叉;通气效率(VE/VCO2≤34)和运动振荡通气缺失可进一步风险分层,提示现行转诊标准需重新评估。
要点
- 峰值耗氧量<12 mL/kg/min单独不足以可靠识别需移植的高危心衰患者。
- VE/VCO2≤34或无运动振荡通气与长期死亡风险减半相关。
- 联合VE/VCO2和运动振荡通气可区分四组显著不同的10年结局风险。
核心结论
- 当代实践中,峰值耗氧量<12 mL/kg/min单独不能可靠识别短期死亡率足够高而需转诊心脏移植的心衰患者。
- VE/VCO2和运动振荡通气提供重要附加风险分层,支持重新评估移植转诊标准。
研究设计与样本
- 回顾性分析8060例动态心衰患者,均有心肺运动试验数据。
- 主要分析纳入2010至2022年间1218例左室射血分数<40%且峰值耗氧量<12 mL/kg/min的患者。
- 生存结局为死亡、左室辅助装置或心脏移植复合终点,与INTERMACS注册中心移植受者比较。
- 按VE/VCO2>34 vs ≤34及运动振荡通气有无进行分层。
- 采用Kaplan-Meier曲线、log-rank检验和Cox比例风险模型,移植生存曲线由汇总数据重建。
主要发现
- 峰值耗氧量<12 mL/kg/min患者生存优于心脏移植受者,生存曲线约2.7年交叉。
- VE/VCO2≤34者10年死亡风险减半(p<0.01),生存曲线约第4年与移植受者交叉。
- 无运动振荡通气同样与长期死亡风险降低50%相关。
- 联合VE/VCO2和运动振荡通气识别出四组10年结局显著不同的风险组(p<0.01)。
- 峰值耗氧量<12 mL/kg/min、VE/VCO2≤34且无运动振荡通气者第5年生存与移植受者相当。
关键数值与推荐
- 现行指南推荐峰值耗氧量<12 mL/kg/min的动态心衰患者评估心脏移植。
- VE/VCO2≤34与10年死亡风险减半相关(p<0.01)。
- 无运动振荡通气与长期死亡风险降低50%相关。
- 联合VE/VCO2和运动振荡通气分组的四组10年结局差异显著(p<0.01)。
临床怎么用
- 对峰值耗氧量<12 mL/kg/min的动态心衰患者,应结合VE/VCO2和运动振荡通气进行综合风险分层。
- VE/VCO2≤34且无运动振荡通气者短期死亡风险可能较低,可考虑暂缓移植转诊。
- 现行仅基于峰值耗氧量<12 mL/kg/min的转诊标准需结合当代心衰管理重新评估。
局限性
- 回顾性分析设计。
- 移植受者生存曲线由汇总数据重建,非个体数据直接比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines recommend evaluating patients with ambulatory heart failure (HF) for heart transplantation if their peak oxygen consumption (peak VO2) is <12 mL/kg/min. However, these recommendations are based on decades-old data. METHODS: We retrospectively analysed 8060 patients with ambulatory HF with cardiopulmonary exercise testing (CPET) data. The primary analysis focused on 1218 patients with left ventricular ejection fraction <40% and peak VO2 <12 mL/kg/min, enrolled between 2010 and 2022. Survival outcomes (composite of death/left ventricular assist device/heart transplantation) were compared with those of heart transplantation recipients from the International Society for Heart and Lung Transplantation registry. Patients were stratified by ventilatory efficiency (ventilation versus CO2 production slope (VE/VCO2) >34 vs ≤34) and presence of exercise oscillatory ventilation. Survival analyses were performed using Kaplan-Meier curves compared with log-rank tests and Cox proportional hazards models, with heart transplantation survival curves reconstructed from aggregate data. RESULTS: Patients with peak VO2 <12 mL/kg/min demonstrated better survival than heart transplantation recipients, with survival curves intersecting at approximately 2.7 years. Among those with VE/VCO2 ≤34, 10-year mortality risk was halved (p<0.01), with survival curves crossing those of heart transplantation recipients around year 4. Absence of exercise oscillatory ventilation was similarly associated with a 50% lower long-term mortality. Combining VE/VCO2 and exercise oscillatory ventilation identified four distinct risk groups with significantly different 10-year outcomes (p<0.01). Patients with peak VO2 <12 mL/kg/min, VE/VCO2 ≤34 and no exercise oscillatory ventilation exhibited survival comparable to heart transplantation recipients at year 5. CONCLUSIONS: In contemporary practice, a peak VO2 <12 mL/kg/min alone may not reliably identify patients with HF with sufficiently high short-term mortality to warrant heart transplantation referral. VE/VCO2 and exercise oscillatory ventilation provide important additional risk stratification, supporting re-evaluation of transplant referral criteria to reflect improved HF management and outcomes.
引用
- Azar, Apostolo, Salvioni, et al. Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current era. Heart. 2026. PMID: 41672767. doi:10.1136/heartjnl-2025-327208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。